Raising awareness for the sarcoma cancer chordoma.

HRES 937 is a non-binding House resolution raising awareness about chordoma, a rare bone cancer affecting the skull and spine. It directly addresses chordoma patients and families globally (including approximately 300 new U.S. diagnoses annually) who face limited treatment options and high recurrence rates. The resolution expresses the House’s sense that increased funding is needed for accurate diagnosis, new treatment development, faster research-to-treatment translation, and patient-centered drug discovery. As a symbolic measure, it does not allocate funds but urges greater support for this underserved cancer community.